Pruritic Papular Eruption associated with HIV-etiopathogenesis evaluated by clinical, immunohistochemical, and ultrastructural analysis

Journal of Dermatology

Volumn 32, Issue 7, 2005, Pages 549-556

  Ramos, Heloisa ^a   Pagliari, Carla ^b   Takakura, Cleusa Fumica Hirata ^b   Sotto, Mirian Nacagami ^b   Duarte, Maria Irma Seixas ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HIV AIDS; Immunohistochemistry; Papular eruption

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL INFILTRATION; CELL ULTRASTRUCTURE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EOSINOPHIL; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATORY INFILTRATE; LANGERHANS CELL; LYMPHOCYTE COUNT; PAPULAR SKIN DISEASE; PATHOGENESIS; PRURITIC PAPULAR ERUPTION; PRURITUS; QUANTITATIVE ANALYSIS; SKIN BIOPSY; SKIN INFILTRATE; TH2 CELL;

EID: 23944444485     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00797.x     Document Type: Article

References (45)

1. James W, Redfield RR, Lupton GP, et al: A papular eruption associated with human T cell lymphotropic type III disease, J Am Acad Dermatol, 13: 563-566, 1985.
2. Colebunders R, Mann JM, Frances H, et al: Generalized pruritic papular eruption in African patients with Human Immunodeficiency Virus infection, AIDS, 1: 117-122, 1987.
3. Hira SK, Wadhawan D, Kamanga J, et al: Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia, J Am Acad Dermatol, 19: 451-457, 1988.
4. Odio W, Kapita B, Mbendi N: Le syndrome d'immunodéficience acquise (sida) à Kinshasa: observations cliniques et épidé miologiques, Ann Soc Belg Med Trop, 65: 357-361, 1985.
5. Pallangyo KJ: Cutaneous findings associated with HIV disease including AIDS experience from Sub Saharan Africa, Trop Doct, 22: 35-41, 1992.
6. Aguirre L, Braz T, Medeiros B, Guimarães A: Manifestaç ões cutâneas em pacientes HIV positivos-Estudo de 818 casos, in: 52° Congresso da Sociedade Brasileira de Infectologia, Annals, Brasília, 1997, p 17.
7. Gava RK, Carvalho MSB, Lopes MLAA, Hinrichsen SL: Lesões cutâneas em pacientes com a sídrome da imunodeficiência adquirida (AIDS). Estudo clínico de 100 pacientes, in: IX Congresso Brasileiro de Infectologia, Annals, Recife, 1996. p 92.
8. Oliveira IF, Straatnann A, Fohr G, Portugal E, Fonseca Jr L, Barreto EM: Manifestações dermatologicas em HIV/AIDS, In: 52° Congresso Brasileiro de Dermatologia, Anais, Brasília, 1997, p 19.
9. Porro AM, Accetturi CA, Almeida FA: Lesões cutâneo-mucosas em pacientes HIV-positivos, Jornal Dermatológico, 35: 2, 1990.
10. Rosatelli JB, Machado AA, Roselino AMF: Dermatoses among Brazilian HIV-positive patients: correlation with the evolutionary phases of AIDS, Int J Dermatol, 36: 729-734, 1997.
11. Banuls J, Ramon D, Aniz E, et al: Papular pruritic eruption with human imunodeficiency virus infection, Int J Dermatol, 30: 801-803, 1991.
12. Bason MM, Berger TG, Nesbitt LT: Pruritic papular eruption of HIV disease, Int J Dermatol, 32: 784-789, 1993.
13. Hevia O, Jimenez-Acosta F, Ceballos PI, Gould EW, Penneys NS: Pruritic papular eruption of the acquired immunodeficiency syndrome: A clinicopathologic study, J Am Acad Dermatol, 24: 231-235, 1991.
14. Ishii N, Nishiyama T, Sugita Y, Nakajima H, Aoki I: Pruritic papular eruption of the acquired immunodeficiency syndrome, Acta Derm Venereol, 74: 219-220, 1994.
15. Rosen T: Pruritic papular eruption of AIDS, J Am Acad Dermatol, 25: 866-867, 1991.
16. Smith KJ, Skelton HG, James WD, et al: Papular eruption of human immunodeficiency virus disease: A review of the clinical histological and immunohistochemical findings in 48 cases, J Am Dermatopathol, 13: 445-451, 1991.
17. Blauvelt A, Katz SI: The skin as target, vector, and effector organ in human immunodeficiency virus disease, J Invest Dermatol, 105 (Supl 1): 122-126, 1995.
18. Duvic M: Human immunodeficiency virus and the skin: selected controversies, J Invest Dermatol, 105 (supl 1): 117-121, 1995.
19. Belsito DV, Sanchez MR, Baer RL, Valentini F, Thorbecke J: Reduced Langerhans' cell IA antigen and ATPase activity in patients with the Acquired Immunodeciency Syndrome, N Engl J Méd, 310: 1279-1282, 1984.
20. Henry M, Uthman A, Ballaun C, Stingl G, Tschachler E: Epidermal Langerhans cells of AIDS patients express HIV-1 regulatory and structural genes, J Invest Dermatol, 103: 593-596, 1994.
21. Zambruno G, Mori L, Marconi A, et al: Detection of HIV-1 in epidermal Langerhans cells of HIV-infected patients using the polymerase chain reaction, J Invest Dermatol, 96: 79-82, 1991.
22. Barker E, Mackewicz, Levy JA: Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival, Proc Natl Acad Sci, 92: 1135-1139, 1995.
23. Lawrence CE, Callanan BJ, Willet BJ, Jarret O: Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study, Immunology, 85: 568-574, 1995.
24. Caterino-de-Araujo A: The CD4+ T-cell network and the cytokine profile after HIV-1 infection, Braz J Med Biol Res, 28: 2-6, 1995.
25. Clerici M, Shearer GMA: TH1-TH2 switch is a critical step in the etiology of HIV infection, Immunol Today, 14: 107-110, 1993.
26. Balter M: Cytokines move from the margins into the spotlight, Science, 268: 205-206, 1995.
27. Ferrer S, Baselga E, Domingo P, et al: Fuliculitis pustulosa eosinofílica en el Síndrome de Immunodeficiencia Adquirida. Presentación de seis casos, Rev Clin Esp, 195: 92-96, 1995.
28. Duarte MIS, Mariano ON, Takakura CFH, Uip DE, Corbett CEP: Fast method for processing biologic material for electron microscopic diagnosis in infectious disease, Ultrastruct Pathol, 16: 475-482, 1992.
29. Nandwani R, Gazzard BG, Barton SE, Hawkins DA, Zemelman V, Saughton RCD: Does HIV disease progression influence epidermal Langerhans cell density?, Br J Dermatol, 134: 1087-1092, 1996.
30. Zemelman V, Van Neer F, Roberts N, Patel P, Langtry J, Staughton RCD: Epidermal Langerhans cells, HIV-1 infection and psoriasis, Br J Dermatol, 130: 307-311, 1994.
31. Forrest DM, Seminari E, Hogg RS: The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs, Clin Infect Dis, 27: 1379-1385, 1998.
32. Brodt HR, Kamps BS, Gute P: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy, AIDS, 11: 1731-1738, 1997.
33. Palella FJ, Delaney KM, Moorman AC: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection, N Eng J Med, 338: 853-860, 1998.
34. Berger R, Gartner S, Rappersberger K, Foster CA, Wolff K, Sting G: Isolation of Human Immunodeficiency Virus type I from human epidermis: virus replication and transmission studies, J Invest Dermatol, 99: 271-277, 1992.
35. Smith KJ, Skelton HG, Yeager J, et al: Histopathologic and immunohistochemical findings associated with inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage, J Am Acad Dermatol, 28: 174-184, 1993.
36. Rosatelli JB, Soares FA, Roselino AMF: Pruritic papular eruption of the acquired immunodeficiency syndrome: Predominance of CD8+ cells, Int J Dermatol, 39: 873-874, 2000.
37. Smith K, Skelton HG, Yeager J, Tuur S, Angritt P, Wagner KF: Histophatologic features seen in cutaneous photoeruptions in HIV-positive patients, Int J Dermatol, 36: 745-753, 1997.
38. Carr A, Vasak E, Munro V, Penny R, Cooper DA: Immunohistological assesment of cutaneous drug hypersensitivy in patients with HIV infection, Clin Exp Immunol, 97: 260-265, 1994.
39. Aires JM, Rosatelli JB, Figueiredo JFC, Roselino AMF: Cytokines in the pruritic papular eruption of HIV, Int J Dermatol, 39: 903-906, 2000.
40. Leung DYM: Atopic dermatitis: Immunobiology and treatment with immune modulators, Clin Exp Immunol, 107: 25-30, 1997.
41. Jordaan HF, Schneider JW: Papular urticaria: A histopathologic study of 30 patients, Am J Dermatopathol, 19: 119-126, 1997.
42. Penneys NS, Noyar J, Bernstein H, et al: Chronic pruritic eruption in patients with acquired immunodeficiency syndrome associated with increased antibody titers to mosquito salivary gland antigens, J Am Acad Dermatol, 21: 421-425, 1989.
43. Diven DG, Newton RC, Ramsey KM: Heightened cutaneous reactions to mosquito bites in patients with acquired immunodeficiency syndrome receiving zidovudine, Arch Intern Med, 148: 2296, 1988.
44. Paganelli R, Scala E, Ansotegui IJ, et al: CD8+ T lymphocytes provide helper activity for IgE synthesis in Human Immunodeficiency Virus-infected patients with hyper-IgE, J Exp Med, 181: 423-428, 1995.
45. Maggi E, Manetti R, Annunziato F, et al: Functional characterization and modulation of cytokine production by CD8+ T cells from Human Immunodeficiency Virus infection individuals, Blood, 89: 3672-3681, 1997.